2R 4S-ItraconazoleAlternative Names: Isomeric itraconazole; Itraconazole - Sepracor; Itraconazole isomer
Latest Information Update: 24 Jan 2001
$50 / €47 *
At a glance
- Originator Janssen L.P.
- Developer Janssen L.P.; Sepracor
- Class Antifungals
- Mechanism of Action 14-alpha demethylase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 24 Jan 2001 Discontinued-Preclinical for Mycoses in USA (IV)
- 24 Jan 2001 Discontinued-Preclinical for Mycoses in USA (Topical)
- 09 Jul 1997 New profile